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Abstract
Background: Cytokinesis is the final step of cell division taking place at the end of mitosis during
which the cytoplasmic content and replicated chromosomes of a cell are equally partitioned
between the two daughter cells. This process is achieved by the formation and the ingression of an
actomyosin contractile ring under the control of equatorial microtubules. The mechanisms of
contractile ring formation are not fully understood but involve recruitment of preexisting actin
filaments and de novo actin polymerisation.
Results: In this study, we evaluated the role of the actin nucleation factor, Arp2/3 complex, during
cytokinesis. We found that the Arp2/3 complex is recruited late to the cleavage furrow suggesting
a potential involvement of Arp2/3 complex during this process. Furthermore, wiskostatin a potent
inhibitor of N-WASP activity towards the Arp2/3 complex blocked cytokinesis without affecting
mitosis. Nonetheless, this inhibition could not be reproduced using alternative approaches
targeting the N-WASP/Arp2/3 complex pathway.
Conclusion: We conclude that the wiskostatin induced defective cytokinesis does not occur
through the inhibition of the N-WASP/Arp2/3 pathway. Wiskostatin is likely to either directly
target other proteins required for cytokinesis progression or alternately wiskostatin bound to N-
WASP could affect the activity of other factors involved in cytokinesis.
Background
Cytokinesis is essential to cell growth and has to be tightly
regulated to insure equal distribution of the cytoplasm
content and newly replicated chromosomes within two
daughter cells at the end of mitosis. Defective chromo-
some segregation or daughter cell separation can alter
chromosome number, which is commonly found in
tumour cells and potentially involved in cancer develop-
ment [1]. For these reasons it is essential to understand
the signalling pathways that coordinate mitotic exit and
cytokinesis.
In metazoans, the central spindle forms during anaphase
between the two sets of chromosomes. Simultaneously,
the cleavage furrow composed by actin and myosin II fil-
aments is established at the cell equator under the control
of peripheral microtubules (central spindle and/or
peripheral astral microtubules) [2]. Thus, constriction of
the actomyosin ring can only start once the two sets of
chromosomes are segregated, insuring genome integrity.
The two daughter cells stay connected by a cytoplasmic
bridge with the midbody in the centre for several hours
until the bridge is finally severed during abscission [3].
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The small GTPase RhoA has been shown to play a major
role in cleavage furrow establishment. Indeed, the GTPase
exchange factor (GEF) ECT2 is specifically recruited at the
cell equator under the control of the centralspindlin com-
plex (MKLP1/MgcRacGAP) also required for central spin-
dle formation [3-7]. Once activated, RhoA induces,
through its effector ROCK, the phosphorylation of
myosin regulatory light chain (MRLC), which is necessary
for contractile ring formation and ingression [3].
In mammals, actin filaments present in the contractile
ring derive from preexisting F-actin flux and de novo actin
polymerisation [8]. In S. pombe, cleavage furrow establish-
ment and activity depend on de novo actin polymerisation
driven by the two main actin nucleation factors: the Arp2/
3 complex and a formin (Cdc12) [9,10]. Arp2/3 complex
is activated by Myo1 and WSP1 at the equator and is
involved in the maturation and/or the maintenance of the
cleavage furrow [11,12]. In mammals the mDia formins,
orthologs of Cdc12 and RhoA effectors, are required for
cytokinesis [13,14]. In agreement with a conserved mech-
anism for cleavage furrow formation and activity, the
Arp2/3 complex and its activator WASP/N-WASP,
ortholog of WSP1, were found to potentially play a role
during cytokinesis [15-19].
In this study the functional role of the Arp2/3 complex
during cytokinesis in mammalian cells was evaluated. We
demonstrated that Arp2/3 complex is recruited late to the
cleavage furrow. Consequences of the inhibition of
WASP/N-WASP activity towards the Arp2/3 complex dur-
ing cytokinesis were then studied using the newly identi-
fied inhibitor: wiskostatin [20]. We show that wiskostatin
strongly inhibits cytokinesis inducing cell binucleation
without affecting the cell cycle. However, these results are
unlikely related to the Arp2/3 complex function since the
wiskostatin induced phenotype could not be validated
using N-WASP and/or Arp2/3 RNA interference approach.
This novel effect of wiskostatin on cytokinesis is also not
related to another known unexpected effect of this com-
pound i.e. ATP depletion [21].
This study that was originally designed to study N-WASP/
Arp2/3 complex pathway during cytokinesis, unexpect-
edly highlighted a novel effect of wiskostatin. For this rea-
son, wiskostatin will have to be used with caution in
future experiments.
Results
Localisation of Arp2/3 complex during mitosis
In mammalian cells, the localisation of endogenous Arp2/
3 complex during mitosis is currently unknown. In order
to study the function of the N-WASP/Arp2/3 complex
pathway during cytokinesis, we thus analyzed the subcel-
lular localisation of Arp3 and p34 (ARPC2) subunits of
the Arp2/3 complex by indirect immunofluorescence. In
interphase HeLa cells using monoclonal anti-Arp3 anti-
body, the Arp2/3 complex was found to be diffuse and
associated with vesicle-like structures in the cytoplasm but
also accumulated in cortical F-actin-rich structures, which
are likely lamellipodia (data not shown). To better visual-
ize cytoskeleton bound Arp2/3 complex in mitotic cells,
the cytosolic unbound fraction was eliminated by perme-
abilising the cells prior to fixation (Fig. 1). Under these
conditions, Arp3 presented a diffuse vesicular-like locali-
sation and was not particularly enriched into the nascent
cleavage furrow during anaphase (Fig. 1, a, arrowhead).
However, during late telophase, once the cleavage furrow
is fully contracted, Arp3 was strongly enriched in the close
vicinity of the contractile ring, as visualized by the F-actin
staining (Fig. 1, h, arrowhead). Furthermore, the vesicu-
lar-like localisation of Arp3 was organised around the
minus-end and along microtubules (Fig. 1, e, arrowhead).
In cytokinesis, when the cytoplasmic bridge between the
two daughter cells extended, Arp3 colocalised with F-actin
in the cortex facing the cytoplasmic bridge (Fig. 1, l,
arrowhead) and within vesicle-like structures (Fig. 1, i and
1j, arrows). Furthermore, the Arp2/3 complex also local-
ised within the cytoplasmic bridge but not in the midbody
(see Additional file 1). This subcellular localisation of
Arp2/3 complex was further confirmed by using a polyclo-
nal antibody directed against p34 subunit (see Additional
file 1). Thus, the localization of Arp2/3 complex is in
agreement with a potential functional role during cytoki-
nesis.
Wiskostatin inhibits cytokinesis but not mitosis
The mammalian ortholog of WSP1, WASP/N-WASP, is
regulated by autoinhibition essentially relieved by bind-
ing of activated small GTPase Cdc42 and/or phosphatidyl
inositol 4,5-biphosphate (PtdIns[4,5]P2) [10,22]. GTP
loaded Cdc42 binds to the GBD (GTPase binding
domain) of WASP/N-WASP, which is preceded by a basic
region where PtdIns[4,5]P2 interacts [22]. Wiskostatin is a
recently identified WASP/N-WASP chemical inhibitor
designed to bind to the GBD [20]. Wiskostatin not only
prevents Cdc42 binding, but also stabilises the autoinhib-
ited state of this actin nucleation promoting factor [20].
This led us to use wiskostatin to investigate the role of the
Arp2/3 complex activated by WASP/N-WASP during cyto-
kinesis.
HeLa cells stably expressing GFP-tagged histone H2B
(HeLa GFP-H2B) were synchronised in prometaphase
with nocodazole and were released for various times after
shake-off in presence of vehicle (DMSO) or increasing
concentration of wiskostatin (from 1 – 10 μM). Cell DNA
content was determined by flow cytometry at 0, 120 and
300 minutes after nocodazole release. In control condi-
tions, at T = 0, cells had a 4N content confirming mitosisBMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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synchronisation mediated by nocodazole. 120 minutes
later half of the cells had exit mitosis and displayed a 2N
content. Finally, 300 min after release, control cells were
mostly in G1 phase (diploid cells, 2N) (Fig. 2A). In con-
trast, under wiskostatin treatment, the number of tetra-
ploid cells (4N) was abnormally elevated at 120 min after
release suggesting a mitotic delay both at 5 and 10 μM
doses (Fig. 2A). 300 minutes after nocodazole release
under 5 μM wiskostatin, half of the cells had a 2N content
while under 10 μM wiskostatin treatment all cells were
tetraploid indicating that they did not proceed through
mitosis (Fig. 2A). Thus wiskostatin inhibits mitotic pro-
gression in a dose dependent manner.
The increased number of tetraploid cells under wiskosta-
tin could either result from an inhibition of mitosis or
cytokinesis. To answer this question, we first analysed the
status of cyclin B1, which is degraded at the metaphase/
anaphase transition. Mitotic HeLa cells were released in
presence of vehicle alone or wiskostatin (10 μM), and cyc-
lin B1 levels were determined by immunoblot analysis
(Fig. 2B). No difference in the kinetics of cyclin B1 degra-
dation was observed between control and wiskostatin
treated cells. This result was further confirmed by studying
another mitotic marker, the phosphorylation of histone
H3 on serine 10 (Ser 10) which correlates with chromatin
condensation [23]. As expected, histone H3 phosphoryla-
tion was not affected by wiskostatin treatment (Fig. 2B).
Equal sample loading was confirmed by cofilin immuno-
blot analysis (Fig. 2B). These results clearly demonstrate
that wiskostatin does not inhibit mitotic progression.
Taken altogether, our results indicate an effect of wiskosta-
tin on cytokinesis. Cytokinesis failure is generally associ-
ated with cell binucleation. To investigate this hypothesis,
nocodazole synchronised HeLa GFP H2B cells were grown
in presence of vehicle alone or wiskostatin (10 μM), fixed
after 300 minutes and binucleated cells were quantified.
In control condition, around 7% of cells were found to be
binucleated (7.26% SEM ± 2.11, n = 536). In contrast,
85% of wiskostatin treated cells contained two nuclei
(84.79% SEM ± 3.44, n = 569) (Fig. 2C). To rule out any
Arp3 localisation during mitosis and cytokinesis Figure 1
Arp3 localisation during mitosis and cytokinesis. HeLa cells were enriched in mitosis after thymidine and RO3306 
blocks (see Methods for details). Two hours after release from RO3306 block cells were permeabilised and fixed. Cells were 
treated for indirect Alexa 555 localisation of Arp3 (a, e, and i) and Alexa 350 localisation of β-tubulin (c, g and k) with specific 
antibodies. F-actin was visualised with FITC-coupled phalloidin (b, f, and j). Merged images are presented (d, h and l). Images are 
representative of the different stages of mitosis: anaphase (a-d), late telophase (e-h) and cytokinesis (i-l). Bars, 10 μm.BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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cooperative effects of nocodazole and wiskostatin, asyn-
chronous HeLa GFP-H2B cells were grown in presence of
5 μM wiskostatin for 24 hours and binucleated cells were
counted as previously described. Under these conditions
more than 26% of cells were found to be binucleated
(26.24%, SEM ± 0.92, n = 640) compared to 0.3% (0.3%,
SEM ± 0.3, n = 629) of cells treated with vehicle alone (Fig.
2D). Similar results were obtained with NIH3T3 and XL2
cells (data not shown). This result clearly demonstrates
that wiskostatin affects mitotic exit.
Wiskostatin inhibits cytokinesis but not mitosis Figure 2
Wiskostatin inhibits cytokinesis but not mitosis. A. HeLa cells were synchronised in prometaphase with nocodazole and 
treated with vehicle or indicated concentrations of wiskostatin. Cells were harvested at indicated time points and DNA con-
tent determined by FACS analysis. A similar scale was used for each histogram. This result is representative of at least 3 inde-
pendent experiments. B. HeLa cells synchronised as previously described were treated with vehicle (-) or 10 μM wiskostatin 
(+) and harvested at indicated time points. Cyclin B1, phosphorylation of Ser 10 of histone H3 and cofilin levels were deter-
mined by immunoblot analysis with specific antibodies. This result is representative of at least 5 independent experiments. C. 
HeLa cells stably expressing GFP-tagged histone H2B were synchronised as previously described, treated with vehicle (Con-
trol) or 10 μM wiskostatin (Wiskostatin 10 μM) and fixed after 300 minutes. F-actin was stained and nuclei per cell deter-
mined. Percentage of binucleated cells was then calculated. 536 cells treated with vehicle and 569 cells treated with wiskostatin 
were count from three independent experiments. Error bars represent standard error of the mean (SEM). D. Assynchronous 
HeLa cells stably expressing GFP-tagged histone H2B were treated with vehicle (Control) or 5 μM wiskostastin (Wiskostatin 5 
μM) for 24 hours and were then fixed. Percentages of binucleated cells were determined as previously indicated. 629 cells 
treated with vehicle and 640 cells treated with wiskostatin were count from three independent experiments. Error bars repre-
sent SEM. Representative images from time lapse movies of HeLa cells stably expressing GFP-tagged histone H2B synchronised 
as previously described, treated with vehicle (E) or 10 μM wiskostatin (F). Images represent merged between DIC and fluores-
cent (Histone H2B) images. Time indicated as hours: minutes.BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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In order to analyse wiskostatin induced cytokinesis
defects in more details, time-lapse microscopy was used.
In vehicle treated HeLa GFP-H2B cells cytokinesis started
around 45 minutes after release from nocodazole block
(Fig. 2E, see Additional file 2). After complete cleavage
furrow contraction, daughter cells were linked to each
other by a cytoplasmic bridge, which extended over time
with the midbody  in its centre (Fig. 2E, arrowheads).
Finally, after several hours, abscission occurred. Under
wiskostatin treatment, cytokinesis started with the same
kinetics as control cells (Fig. 2F, see Additional file 3) but
prior and during cleavage furrow contraction blebs were
visible at cell poles (Fig. 2F, arrowheads). Finally, once the
cleavage furrow fully contracted, the cytoplasmic bridge
did not extend, the contractile ring relaxed and daughter
cells finally fused-back together (Fig. 2F, arrows).
We then studied the organisation of the cytoskeleton in
more details. Mitotic HeLa cells stably expressing GFP-
tagged β-Tubulin were fixed two hours after nocodazole
release in presence of vehicle or 10 μM wiskostatin, and
were stained for F-actin and DNA. During cytokinesis, the
microtubule bundles of the central spindle, which are not
associated with kinetochores, are compacted by the con-
traction of the cleavage furrow. In control cells, these com-
pacted bundles were clearly visible between the two
daughter cells (Fig. 3A, b, arrowhead). Similarly in wisko-
statin treated cells, compacted microtubule bundles were
also present between newly assembled nuclei but cells
were binucleated (Fig. 3A, f, arrowhead). Cleavage furrow
relaxation induced by wiskostatin was not associated with
obvious F-actin reorganisation and some cleavage furrow
remnant could be observed surrounding the central spin-
dle as evidenced by F-actin staining (Fig. 3A, e, arrow-
head). Relocalisation of ECT2 from the central spindle in
anaphase to the midbody during cytokinesis was also not
altered by wiskostatin treatment (data not shown) con-
firming that wiskostatin did not affect cleavage furrow for-
mation and initial contraction.
We next studied the localisation of Arp3 during cytokine-
sis under wiskostatin treatment. As previously showed,
Arp3 was enriched within the cleavage furrow once fully
contracted in vehicle treated cells at the end of telophase
(Fig. 3B, a, arrowhead). Under wiskostatin treatment,
Arp3 localisation within the contractile ring was reduced
(Fig. 3B, e, arrowhead). In addition, wiskostatin induced
the clustering of Arp3 within vesicle-like structures
throughout the cell (Fig. 3B, e, arrow).
Altogether, our results showed that wiskostatin inhibited
late cell cycle events required for abscission to occur.
Wiskostatin induced cleavage furrow regression was asso-
ciated with a reduced localisation of Arp2/3 complex
within the contractile ring.
Wiskostatin effects onto cytokinesis are not reproduced by 
alternative inhibition of the N-WASP/Arp2/3 pathway
In order to study whether the mislocalisation of Arp3,
induced by wiskostatin, was responsible for defective
cytokinesis, we used alternative approaches to inhibit N-
WASP and Arp2/3 complex activities. We first knocked-
down N-WASP and Arp3 protein levels using an siRNA
approach. N-WASP and Arp3 expressions were strongly
reduced in cells treated for 72 hours with specific siRNA
(more than 80% inhibition) as demonstrated by immu-
noblot analysis (Fig. 4A). As previously shown, Arp3
knockdown is associated with down-regulation of other
Arp2/3 subunits [24] as revealed by the strong inhibition
of p34 expression in Arp3 null cells (Fig. 4A). The DNA
content of siRNA treated cells was then evaluated by flow
cytometry in order to study the consequences of N-WASP
and/or Arp3 depletion on cytokinesis. No major differ-
ences between control cells and cells transfected with N-
WASP and/or Arp3 siRNAs were observed (Fig. 4B). In
contrast, tetraploid and also octaploid cells accumulated
when transfected with siRNA inhibiting ECT2 protein
expression (Fig. 4A, more than 90% inhibition), a major
effector of cytokinesis (Fig. 4B, arrows). The phenotypes
resulting from siRNA transfection were also evaluated by
indirect immunofluorescence analysis. Cellular morphol-
ogy, F-actin organisation and Arp3 staining were not
affected in control and N-WASP knockdown cells (see
Additional file 4). In contrast, Arp3 staining was greatly
reduced in cells transfected with Arp3 siRNA for 72 hours.
The morphology of these cells was altered as they
appeared rounder and smaller, a phenotype likely due to
the disorganization of the F-actin network (see Additional
file 4). During cytokinesis, Arp3 recruitment to the con-
tractile ring was only reduced in Arp3 null cells but not in
control and N-WASP null cells (see Additional file 4). We
obtained similar results using other siRNAs targeting N-
WASP and Arp3 sequences (data not shown). Our data
suggest that Arp2/3 complex localisation within the cleav-
age furrow does not rely on N-WASP and is not manda-
tory for cytokinesis to occur.
In order to investigate possible subtle consequences of N-
WASP and/or Arp3 losses on mitosis/cytokinesis, siRNA
treated cells were studied by time-lapse microscopy. The
time-lapse experiment began 24 hours after siRNA trans-
fection when protein expression was significantly reduced
(see Additional file 4) and cells were imaged every 30
minutes for 30 hours. No differences in terms of fre-
quency and kinetics of mitosis and cytokinesis were
observed between control cells (Fig. 4C and see Addi-
tional file 5), N-WASP null-cells (Fig. 4C and see Addi-
tional file 6), Arp3 null-cells (Fig. 4C and see Additional
file 7), N-WASP and Arp3 null-cells (Fig. 4C and see Addi-
tional file 8). In contrast, ECT2 knockdown strongly inter-
fered with cell division inducing binucleation andBMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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tetranucleation over time (Fig. 4C and see Additional file
9). Surprisingly, these results suggest that the loss of N-
WASP and/or Arp2/3 complex, are not associated with
cytokinesis failure as we were expecting based on the
effects of wiskostatin. In order to confirm these unex-
pected results, various N-WASP mutants known to inter-
fere with Arp2/3 complex activity were overexpressed and
their effects on cytokinesis evaluated. WASP family pro-
teins are characterized by the presence, at the carboxy-ter-
minus, of three independent domains: the verprolin
homology (V) (a.k.a. WASP homology 2/WH2 domain),
central (C) and acidic (A) regions. These domains form
the so-called VCA module, which is necessary and suffi-
cient to activate Arp2/3-dependent actin polymerisation
in vitro. The V and A regions bind actin monomers and
Arp2/3 respectively, whilst the C region binds Arp2/3 and
induces crucial changes in the tertiary and quaternary
structures of the Arp2/3 complex, thereby regulating the
ability of the Arp2/3 complex to induce actin polymerisa-
tion [10]. Deletion of the A region within the sequence of
WASP family proteins compromises binding to the Arp2/
3 complex. This mutation acts as a dominant negative
protein. On the other hand, overexpression of VCA and
CA modules from WASP family proteins strongly induces
Wiskostatin inhibits late cytokinesis Figure 3
Wiskostatin inhibits late cytokinesis. A. Wiskostatin does not affect microtubule organisation. HeLa cells stably express-
ing GFP-tagged β-tubulin were synchronised in prometaphase with nocodazole and released after a shake-off in presence of 
vehicle (Cont) or 10 μM wiskostatin (Wisko). 120 minutes after release cells were fixed and F-actin (a and e) and DNA (c and 
g) stained respectively with Alexa 555-coupled phalloidin and DAPI. β-tubulin (b and f) was directly visualised. Merged images 
(d and h) are presented. B. Wiskostatin alters Arp3 localisation. HeLa cells were synchronised in G2/M by thymidine and 
RO3306 double block. 120 minutes after release cells were fixed and stained as described in Figure 1. Images a and e represent 
staining of Arp3, b and f staining of F-actin and c and g staining of β-tubulin. Merged images (d and h) are presented. Bars, 10 
μm.BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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Arp3 and/or N-WASP knockdowns do not affect cytokinesis Figure 4
Arp3 and/or N-WASP knockdowns do not affect cytokinesis. A. HeLa cells were transfected with water (Ø) or spe-
cific siRNA directed against N-WASP or Arp3 or N-WASP + Arp3 or ECT2. 72 hours after transfection cells were harvested 
and lysed. N-WASP, Arp3, ECT2, p34 and β-tubulin protein levels were determined by immunoblot analysis using specific anti-
bodies. B. The DNA content of the same HeLa cells was determined by flow cytometry analysis. Arrows indicate abnormal 
DNA content in ECT2 knockdown cells. A similar scale was used for each histogram. These results are representative of at 
least three independent experiments. C. Representative DIC images from time-lapse movies of HeLa cells transfected with 
water (Ø), siRNA directed against N-WASP (N-WASP), against Arp3 (Arp3), against Arp3 and N-WASP (Arp3 + N-WASP) or 
against ECT2. Images started to be acquired 24 hours post-transfection for 40 hours. Coloured stars indicate the nuclei of 
dividing cells and of their daughter cells. Time indicated as hours: minutes.
Table 1: Effect of various N-WASP constructs onto cell ploidy.
Vector Total cell number Number of binucleated cells % of binucleated cells
GFP 419 17 4.06
GFP VCA 527 61 11.57
GFP CA 629 30 4.77
GFP N-WASP 351 19 5.41
GFP N-WASP ΔA 130 7 3.38
NIH3T3 cells were transfected with indicated constructs. Three days after transfection cells were harvested and a fifth seeded onto glass coverslips. 
Two hours after seeding cells were fixed. Nuclei number of transfected cells was determined after F-actin and DNA staining respectively with 
TRITC-coupled phalloidin and DAPI. Total cell number and the number of binucleated cells from a representative experiment are presented as well 
as the deduced percentage of binucleated cells.BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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mislocalised Arp2/3 complex activation and unproduc-
tive Arp2/3 binding respectively [25,26]. These constructs
titrate endogenous Arp2/3 complex and inhibit F-actin
processes depending onto Arp2/3 activity [10]. Vector
expressing GFP, GFP-tagged N-WASP, N-WASP ΔA (dele-
tion of the acidic domain), VCA or CA modules from N-
WASP were transfected in NIH3T3 fibroblasts. Three days
after transfection cells were fixed and binucleated trans-
fected cells counted. Results from a representative experi-
ment are presented in Table 1. As shown, no major
differences were observed between GFP, GFP-tagged N-
WASP, N-WASP ΔA and CA overexpressing cells,
although, overexpression of GFP-tagged VCA slightly, but
consistently, increased cell binucleation (Table 1).
Altogether, our data demonstrated that the inhibition of
N-WASP/Arp2/3 pathway is not sufficient to mimic
wiskostatin effects on cytokinesis. Therefore, it is likely
that wiskostatin affect the activity of additional targets
involved in cytokinesis.
Wiskostatin effect onto cytokinesis is independent of ATP 
depletion
Taken altogether, our results suggest that wiskostatin
effects on cytokinesis progression cannot solely be
explained by the inhibition of N-WASP. During the course
of our study, wiskostatin was shown to induce cellular
ATP depletion [21]. We thus evaluated whether ATP
depletion may interfere with cytokinesis progression.
Mitotic HeLa cells released in presence of vehicle or wisko-
statin (10 μM) from a nocodazole block were harvested at
various time points and lysed for 10 minutes at 100°C in
distilled water. ATP levels were then determined from
clarified lysates using a bioluminescent luciferase assay. In
vehicle (at 300 min, 91.2%, SEM ± 5.3, n = 3) or wiskosta-
tin (at 300 min, 82%, SEM ± 1.5, n = 3) treated cells no
major variation of ATP levels was observed during mito-
sis/cytokinesis (Fig. 5A). In contrast, ATP levels strongly
decreased in cells released in presence of energy poisons
such as sodium azide and 2-deoxy-D-glucose (at 300 min,
41.1%, SEM ± 3.8, n = 3, Fig. 5A).
In order to confirm that inhibition of cytokinesis induced
by wiskostatin was independent of ATP depletion, DNA
content of HeLa cells synchronised and treated as men-
tioned was determined by flow cytometry. Whereas vehi-
cle or ATP depleted treated cells were mainly diploids after
300 minutes from nocodazole release, wiskostatin treated
cells were massively tetraploids and likely binucleated
(Fig. 5B). Interestingly, we observed a delay in exit to
mitosis in ATP depleted cells (Fig. 5B, see 90 min time
point), which was correlated with a delay of cyclin B1 deg-
radation as demonstrated by immunoblot analysis (Fig.
5C). As previously demonstrated, there was no effect of
wiskostatin on cyclin B1 degradation. Time-lapse micros-
copy confirmed that ATP depletion delayed mitotic exit
whereas wiskostatin did not (data not shown).
Our results showed that ATP depletion does not block
mitosis/cytokinesis but simply delays it. Furthermore, we
established that inhibition of cytokinesis by wiskostatin is
independent of ATP depletion suggesting additional tar-
gets for wiskostatin.
Discussion
Partitioning of the two daughter cells following cytokine-
sis is crucial to allow faithful segregation of chromo-
somes. Disrupting the final stages of cytokinesis can lead
to multinucleated cells and genome instability. The
involvement of the actin cytoskeleton during cytokinesis
is now well established. The cleavage furrow is formed
during anaphase by actin and myosin filaments and its
complete ingression allows daughter cell separation at the
end of mitosis. However, little data regarding actin
dynamics during cytokinesis is available. A recent study
showed that actin filaments present within the cleavage
furrow of mammalian cells come from the flux of preex-
isting F-actin and de novo in situ actin polymerisation [8].
However the functional importance of de novo actin
polymerisation or the identity of the nucleation factor
involved remain unanswered questions.
In S. pombe, the two main actin nucleation factors, the
Arp2/3 complex and a formin, are required for cleavage
furrow establishment and activity [9,11]. In mammals,
the involvement of formins during cytokinesis is now well
established suggesting a conserved mechanism between
yeast and mammals for cleavage furrow formation
[3,13,14,27]. However, in metazoan the involvement of
WASP/N-WASP and the Arp2/3 complex during cytokine-
sis is still a matter of debate. Very little information
regarding the function of WASP/N-WASP during cell
growth in general and cytokinesis in particular are availa-
ble. In nematodes, knockdown of WSP-1 protein, the
WASP/N-WASP ortholog, leads to cytokinesis defects
[18]. N-WASP knockout in mouse is embryonic lethal
(E12) and primary fibroblasts isolated from knockout
embryos are unable to grow without being transformed
suggesting an involvement of N-WASP in cell growth
[28,29]. Data regarding the involvement of the Arp2/3
complex during cytokinesis in metazoans are more con-
troversial. In nematode, the requirement of the Arp2/3
complex is unclear since two studies using RNA interfer-
ence lead to conflicting results. Two groups described that
knocking-down most of the Arp2/3 complex subunits
lead to embryonic lethality, however only the group of
Skop et al. showed that these depletions were associated
with early or late cytokinesis defects [16,30]. In Dro-
sophila, the picture is more readable since Arp3 knock-
down in S2 cells led to cell binucleation [15].BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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Furthermore, the Arp2/3 complex is required for the
assembly of two Drosophila embryonic structures highly
related to the cleavage furrow, the pseudocleavage furrow
in syncytial embryos and the ring canal [31,32]. Finally, in
mammals, p21 (ARPC3) subunit of the Arp2/3 complex is
an essential gene, as knockdown results in a block in cell
growth phenotype [33]. However, a potential relation
with a cytokinesis defect was not reported.
In summary, the data available in the literature on the
functional importance of the Arp2/3 complex for cell
growth are clear, however because of the pleïotropic func-
tions of the actin cytoskeleton, specific requirements of
Arp2/3 complex activity for efficient cytokinesis are still
questionable.
In this study, we showed that endogenous Arp3, despite
being localised to the cell cortex, did not accumulate in
the nascent contractile ring. However, once the cleavage
furrow was completely contracted during cytokinesis,
Arp2/3 complex colocalised with F-actin within this struc-
ture. Arp2/3 complex was also found within the cytoplas-
mic bridge linking daughter cells at the end of mitosis in
agreement with the biochemical association of Arp2/3
Wiskostatin does not affect cellular ATP levels Figure 5
Wiskostatin does not affect cellular ATP levels. A. Cellular ATP levels in wiskostatin treated cells. HeLa cells were syn-
chronised in prometaphase with nocodazole and released after shake-off in presence of vehicle (control), 10 mM NaN3 + 6 mM 
deoxyglucose (ΔATP) or 10 μM wiskostatin (wiskostatin). After indicated time points cells were harvested and lysed in boiling 
water for 10 minutes. Cellular ATP contents were determined on clarified lysates using ATP determination kit (see Methods). 
Cellular ATP level at time point 0 from each treatment was defined as 100%. Graph represents mean of three independent 
experiments. Error bars represent SEM. ATP depletion delays mitosis. B. HeLa cells synchronised and treated as previously 
described were harvested at indicated time points and DNA content analysed by flow cytometry. C. In similarly treated cells 
cyclin B1 and γ-tubulin levels were determined by immunoblot analysis using specific antibodies.BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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subunits with the central spindle [16]. The absence of
early specific localisation of Arp3 within the cleavage fur-
row suggests that the Arp2/3 complex is not involved in its
establishment. This is in agreement with the proposed
role of the Arp2/3 complex in fission yeast where it is
recruited late to/around the contractile ring and seems to
be involved in cleavage furrow maintenance by allowing
new plasma membrane addition [12]. New membrane
addition relies on vesicle recruitment and is essential for
cleavage furrow ingression and to seal up daughter cells at
time of abscission [34]. The Arp2/3 complex is involved in
endocytosis, vesicular trafficking but also in the polarised
delivery of certain proteins to the plasma membrane
[35,36]. All these processes are known or supposed to be
important during cytokinesis [34]. We showed that Arp2/
3 complex was enriched in vesicle-like structure localised
on microtubules facing the cytoplasmic bridge between
daughter cells.
We found that inhibition of N-WASP activity towards the
Arp2/3 complex using wiskostatin strongly impaired cyto-
kinesis without affecting mitosis in a dose dependent
manner. Wiskostatin inhibited final stages of cytokinesis,
which correlated with a decrease of the Arp2/3 complex
from the contractile ring and the clustering of the Arp2/3
complex within vesicle-like structures. The late inhibition
of cytokinesis by wiskostatin suggests that the Arp2/3
complex is required at the end of cytokinesis and/or for
abscission in agreement with its late recruitment within
the cleavage furrow. However, we were unable to confirm
these results by knocking-down N-WASP and/or Arp3
protein expression by RNA interference. Moreover, N-
WASP depletion showed that Arp3 localisation within the
cleavage furrow is not dependent upon N-WASP. Differ-
ent possibilities can explain the discrepancy between the
results we obtained using RNA interference versus wisko-
statin. First, we cannot exclude that remaining N-WASP
and/or Arp3 proteins, in siRNA treated cells, are sufficient
to trigger cytokinesis bearing in mind that complete
depletion of these proteins is associated with cell growth
defects and embryonic lethality [29-31,33]. Second,
wiskostatin could have additional targets related or not to
N-WASP. Wiskostatin binds purified N-WASP in vitro but
nothing is known about binding to native N-WASP.
Native N-WASP is predominantly associated with WIP
(WASP-interacting protein), a protein involved in N-
WASP inhibition but also required for N-WASP activation
[37-39]. WIP can regulate F-actin organisation independ-
ently of its effects on N-WASP [39]. Wiskostatin could pre-
vent the release or the binding of WIP or other unknown
proteins. This could have major consequences for the pro-
gression of cytokinesis if such proteins play a role during
this process. Furthermore, this could explain the discrep-
ancy between wiskostatin and N-WASP knockdown
results. Finally, wiskostatin could inhibit additional tar-
gets unrelated to N-WASP. Indeed, wiskostatin was
recently shown to deplete cellular ATP in an irreversible
manner perturbing membrane transport [21]. ATP in gen-
eral and membrane trafficking in particular, as mentioned
above, play crucial roles during mitosis and cytokinesis.
However, we showed that wiskostatin, at the highest con-
centration used in this study (10 μM), did not affect cellu-
lar ATP levels during mitosis/cytokinesis. Thus, inhibition
of cytokinesis induced by wiskostatin is likely independ-
ent to its ATP depleting activity.
The existence of additional targets of wiskostatin is sup-
ported by the results we obtained using N-WASP mutants.
The expression of a dominant negative mutant of N-WASP
towards the Arp2/3 complex (N-WASP ΔA) did not block
cytokinesis suggesting again that N-WASP inhibition is
not sufficient. In contrast, overexpression of N-WASP VCA
domain slightly increased nuclei number. The VCA mod-
ule alters Arp2/3 activity by titrating and delocalising it.
VCA overexpression could either block the activation of
the Arp2/3 complex by another factor than N-WASP
involved in cytokinesis. On the other hand, the increase of
F-actin generated by over-activation of Arp2/3 complex
triggered by VCA overexpression could affect cytokinesis.
This hypothesis is supported by a recent study showing
that expression of a constitutively active mutant of WASP
towards the Arp2/3 complex increases cell binucleation in
a same extend as VCA [19].
Conclusion
Wiskostatin has been designed, as numerous inhibitors,
to specifically inhibit N-WASP activity towards the Arp2/
3 complex. Our studies reveal the caveat of using such an
in vitro approach to identify new compounds. Indeed, in
vivo test may not parallel the in vitro activity and should be
included in the compound characterisation. We show that
wiskostatin inhibits cytokinesis and it is likely that N-
WASP is not its sole target during this process. Our study
is the second report of a non-expected effect of wiskosta-
tin, which suggests that this compound will have to be
used in future with caution. However, it will be of interest
to characterise wiskostatin targets involved in cytokinesis.
The identification of these proteins could be achieved
using a proteomic approach based upon mass spectrome-
try using immobilised wiskostatin over mitotic cell
extracts.
Methods
Reagents and antibodies
All chemicals were purchased from Sigma unless other-
wise stated. Monoclonal antibodies against Arp3, β-tubu-
lin (TUB 2.1) and γ-tubulin (GTU-88) were from Sigma.
Polyclonal antibody against p34 (ARPC2) was from
Upstate Biotechnology. Polyclonal antibodies against N-
WASP (H-100), cyclin B1 (GNS1) and ECT2 (C-20) wereBMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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purchased from Santa-Cruz Biotechnology. Polyclonal
antibody against cofilin was from Cytoskeleton. Mono-
clonal antibody against p-histone H3 (Ser 10) was from
Euromedex. Polyclonal antibody against β-tubulin was a
generous gift from Jose M. Andreu (Centro de Investiga-
ciones Biológicas, Madrid, Spain). Goat Alexa 350, 488,
555, 680-conjugated anti-mouse and anti-rabbit were
from Molecular Probes.
Expression plasmids
Vector encoding EGFP-tagged bovine N-WASP full-length
(aa, 1–505) and ΔA (aa, 1–484) mutant as well as N-
WASP CA (aa, 455–505) and VCA (aa, 391–505) regions
were from Laura M. Machesky (Beatson Institute, Glas-
gow, UK).
Cell culture and synchronisation
HeLa and NIH3T3 cells were cultured in Dulbecco's Mod-
ified Eagle's medium (DMEM) supplemented with 10%
foetal bovine serum (FBS), 20 mM HEPES and antibiotics.
For HeLa cells stably expressing GFP-H2B (gift from E. Jul-
ien, IGMM, Montpellier, France) media was supple-
mented with 0.2 mg/ml G418.
Cells were synchronised in prometaphase by nocodazole
block. Briefly cells were grown for 12 hours in the pres-
ence of 100 ng/ml nocodazole. Mitotic cells obtained by
shake-off were plated onto dishes or glass coverslips
coated with poly-L-lysine in fresh growth medium con-
taining vehicle alone or wiskostatin. Cells were then har-
vested at indicated time points, treated for fluorescence-
activated cell sorting (FACS), lysed for immunoblot anal-
ysis or fixed for indirect immunofluorescence study. In
some experiments, cells were alternatively synchronised
in G2/M using 10 μM Cdk1 inhibitor (RO3306, Calbio-
chem). Briefly, 8 hours after seeding cells were blocked in
G1/S with 2.5 mM thymidine for 24 hours. After several
washings, cells were released in complete medium con-
taining 24 μM deoxycytine and 10 μM RO3306 for 15
hours. Finally, G2/M blocked cells were released in com-
plete medium containing or not wiskostatin after several
washings and treated for immunofluorescence 2 hours
after release.
RNA interference
siRNA were transfected in HeLa cells using Lipofectamine
2000™ reagent (Invitrogen) according to manufacturer
instructions. Proteins were targeted with the following
sequences: Arp3 with 5'-GCCAAAACCUAUUGAUGUA-
3', N-WASP with 5'-GGUGUUGCUUGUCUUGUUA-3'
and ECT2 with 5'-CAUUUGAUAUGAAGCGUUA-3'. Cells
were harvested 72 hours after transfection for FACS and
immunoblot analysis.
Immnunofluorescence
For immunofluorescence, cells were stained and mounted
on glass slides as previously described [40]. In brief, cells
were fixed with 4% paraformaldehyde in PEM (0.1 mM
PIPES, pH 6.9; 1 mM EGTA; 0.5 mM MgCl2) containing
0.2% Triton X-100 for 10 min at 37°C, blocked with 1%
BSA and stained with phalloidin or the appropriate anti-
bodies diluted in PBS containing 1% BSA. When men-
tioned cells were permeabilised with PEM containing
0.5% Triton X-100 and 1 mM PMSF for 30 seconds prior
fixation with 4% paraformaldehyde. Cells were examined
with a DMR A microscope PL APO 63× oil immersion
objective with appropriate filters (Leica) and images were
recorded with a cooled CCD Micromax camera (Princeton
Instruments) driven by MetaMorph (Molecular Devices).
Time-lapse microscopy was performed using an Axiovert
200 M microscope PlasDIC 32× objective with appropri-
ate filters (Zeiss) and images were recorded with a cooled
CCD Micromax camera (Princeton Instruments) driven
by MetaMorph (Molecular Devices).
Determination of cellular ATP levels
1.5 × 105 mitotic HeLa cells/well in 6 well plates were
treated for indicated time with vehicle alone, 10 μM
wiskostatin or 10 mM NaN3 + 6 mM 2-deoxyglucose (ATP
depletion). Cells were harvested and lysed in boiling dis-
tilled water for 10 min. Lysates were clarified by centrifu-
gation at 20,000 × g for 10 min at 4°C. Cellular ATP levels
were determined from clarified lysates using ATP determi-
nation kit (Proteinkinase, Germany) and following man-
ufacturer instructions. Luminescence was measured using
a MicroLumat (Berthold Technologies) luminometer.
Flow cytometry
Harvested cells were washed in PBS, fixed in 70% ethanol
and kept at -20°C until analysis. DNA was stained with
propidium iodide and analysed with a FACSCalibur (Bec-
ton Dickinson) driven by CellQuest™. The DNA content
of 10 000 cells was determined for each condition.
Abbreviations
WASP: Wiskott-Aldrich syndrome protein; N-WASP: Neu-
ral WASP; Arp: actin-related protein; GBD: GTPase bind-
ing domain.
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Additional material
Additional file 1
p34 (ARPC2) localisation during the exit of mitosis. A. HeLa cells were 
enriched in mitosis after thymidine and RO3306 blocks (see Methods for 
details). Two hours after release from RO3306 block cells were permeabi-
lised and fixed as described in Methods. Cells were treated for indirect 
Alexa 555 localisation of p34 (a and e) and Alexa 350 localisation of β-
tubulin (c and g) with specific antibodies. F-actin was visualised with 
FITC-coupled phalloidin (b and f). Merged images are presented (d and 
h). Images are representative of the different stages of mitosis: late telo-
phase (a-d) and cytokinesis (e-h). During late telophase p34 is enriched 
within the contractile ring (d, arrowhead) During cytokinesis, p34 pre-
sented a vesicular-like staining at the basis of microtubule bundles (e, 
arrowhead) and was found within the cytoplasmic bridge between the two 
daughter cells (e, arrow). Colocalisation with F-actin was also evident at 
the cortex facing the cytoplasmic bridge (h, arrowhead). B. Arp3 and p34 
localisations are undistinguishable HeLa cells prepared as previously 
described were treated for indirect Alexa 555 localisation of Arp3 (a) and 
Alexa 488 localisation of p34 (b) with specific antibodies. DNA was 
stained with DAPI. A merged imaged is presented (d) and highlight the 
strong colocalisation between the two Arp2/3 complex subunits in partic-
ular within the cleavage furrow. Bars, 10 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S1.tiff]
Additional file 2
Mitosis of vehicle treated HeLa GFP-Histone H2B cells. For details see 
figure 2E legend. Frames were taken every 5 min s and are played at six 
frames per second. Time indicated as hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S2.avi]
Additional file 3
Mitosis of wiskostatin (10 μM) treated HeLa GFP-Histone H2B cells. 
For details see figure 2F legend. Frames were taken every 5 min and are 
played at six frames per second. Time indicated as hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S3.avi]
Additional file 4
Study of siRNA efficiency. A. Arp3 knockdown affects cell morphology. 
HeLa cells were transfected with indicated siRNA for 72 hours, permea-
bilised and fixed as previously indicated and treated for indirect Alexa 555 
localisation of Arp3 (a, e and i) using specific antibody. F-actin was 
stained with FITC-coupled phalloidin (b, f and j). Merged images are pre-
sented (c, g and k). Exposure times for Alexa 555 and FITC channels were 
determined for control conditions and applied to N-WASP and Arp3 null 
cells allowing direct comparison of protein levels based on signal intensi-
ties. Arp3 localised at the tip of membrane protrusion (a and e, arrow-
head) and in vesicle-like structures where it colocalised with F-actin (c 
and g). Arp3 staining is greatly reduced in Arp3 null-cells (compare i with 
a and e). Bar, 20 μm. B. Arp3 recruitment to the contractile ring is not 
affected in N-WASP null-cells. HeLa in cytokinesis transfected with 
siRNA as previously described were treated for indirect Alexa 555 locali-
sation of Arp3 (a, e and i) and Alexa 350 localisation of β-tubulin (c, g 
and k) using specific antibodies. F-actin was stained with FITC-coupled 
phalloidin (b, f and j). Merged images (d, h and l) are presented. Expo-
sure times in Alexa 555 and FITC channels were fixed as previously 
described. Arp3 recruitment to the contractile ring is identical between 
control (a, arrowhead) and N-WASP (b, arrowhead) null-cells but is 
greatly reduced in Arp3 null-cells (i, arrowhead). Bar, 10 μm. C. Time 
course depletion of N-WASP, Arp3 and ECT2 proteins by RNA interfer-
ence. HeLa cells were transfected with indicated siRNA and were har-
vested 24, 48 and 72 hours after transfection. Proteins levels were 
determined by immunoblot analysis using specific antibodies. The maxi-
mum of N-WASP knockdown is achieved after 48 hours transfection, 
whereas 72 hours are required for Arp3 and only 24 hours for ECT2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S4.tiff]
Additional file 5
Mitosis of control siRNA treated cells. For details see figure 4C legend. 
Frames were taken every 30 min are played at four frames per second. 
Time indicated as day: hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S5.avi]
Additional file 6
Mitosis of N-WASP siRNA treated cells. For details see figure 4C legend. 
Frames were taken every 30 min are played at four frames per second. 
Time indicated as day: hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S6.avi]
Additional file 7
Mitosis of Arp3 siRNA treated cells. For details see figure 4C legend. 
Frames were taken every 30 min are played at four frames per second. 
Time indicated as day: hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S7.avi]
Additional file 8
Mitosis of N-WASP + Arp3 siRNA treated cells. For details see figure 
4C legend. Frames were taken every 30 min are played at four frames per 
second. Time indicated as day: hours: minutes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2121-9-42-S8.avi]BMC Cell Biology 2008, 9:42 http://www.biomedcentral.com/1471-2121/9/42
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